Page last updated: 2024-10-25

deferoxamine and Fibrosarcoma

deferoxamine has been researched along with Fibrosarcoma in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schuster, L1
Seifert, O1
Vollmer, S1
Kontermann, RE1
Schlosshauer, B1
Hartmann, H1

Other Studies

1 other study available for deferoxamine and Fibrosarcoma

ArticleYear
Immunoliposomes for Targeted Delivery of an Antifibrotic Drug.
    Molecular pharmaceutics, 2015, Sep-08, Volume: 12, Issue:9

    Topics: Cells, Cultured; Deferoxamine; Drug Delivery Systems; Endopeptidases; Fibroblasts; Fibrosarcoma; Gel

2015